Scholar Rock Holding Corp (SRRK)
7.42
+0.35
(+4.95%)
USD |
NASDAQ |
Oct 04, 16:00
7.41
-0.01
(-0.13%)
After-Hours: 20:00
Scholar Rock SG&A Expense (TTM): 58.86M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 58.86M |
March 31, 2024 | 53.95M |
December 31, 2023 | 49.40M |
September 30, 2023 | 47.14M |
June 30, 2023 | 44.27M |
March 31, 2023 | 43.13M |
December 31, 2022 | 43.12M |
September 30, 2022 | 42.67M |
June 30, 2022 | 43.47M |
March 31, 2022 | 41.66M |
December 31, 2021 | 40.27M |
September 30, 2021 | 37.67M |
June 30, 2021 | 34.66M |
March 31, 2021 | 31.76M |
Date | Value |
---|---|
December 31, 2020 | 28.22M |
September 30, 2020 | 26.32M |
June 30, 2020 | 24.22M |
March 31, 2020 | 22.57M |
December 31, 2019 | 20.82M |
September 30, 2019 | 20.40M |
June 30, 2019 | 17.39M |
March 31, 2019 | 16.14M |
December 31, 2018 | 14.38M |
September 30, 2018 | 10.52M |
June 30, 2018 | 8.51M |
March 31, 2018 | 6.227M |
December 31, 2017 | 5.085M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
20.82M
Minimum
Dec 2019
58.86M
Maximum
Jun 2024
38.64M
Average
41.66M
Median
Mar 2022
SG&A Expense (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | 11.53M |
Palatin Technologies Inc | 12.27M |
iBio Inc | 11.67M |
Theriva Biologics Inc | 5.633M |
Oragenics Inc | 6.283M |